Soleno Therapeutics’ $120 Million Common Stock Offering and Private Placement

Wilson Sonsini Goodrich & Rosati and Cooley advised Soleno Therapeutics on the deal.Soleno Therapeutics, Inc. (Nasdaq:SLNO), (“Soleno”) announced the pricing of the underwritten public offering of 3,000,000…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here